Coherus Oncology
CHRS | NASDAQ
$0.51
-$0.02 (-2.95%)
At close: Nov 16, 2026, 4:00 PM ET
$0.51
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:59 PM ET
Coherus Oncology Statistics
Key statistics explainedMarket Data
$78.18M
$64.1M
1.03
1.25M
154.97M
33.33%
46.23%
NASDAQ
US19249H1032
Price Performance
-48.5%
-55.6%
-65.8%
-64.1%
-54.9%
-76.1%
-97.2%
-48.5%
-57.1%
-51.2%
-33.3%
Valuation
-0.53
N/A
-0.01
0.01
1.46
0.90
3.10
-0.45
-0.42
-0.46
1.20
-0.44
-0.45
-0.37
-190.2%
-222.2%
-236.0%
Financial Health
$14.08M
$69.55M
$83.63M
$171.1M
1.47
1.29
2.75
-0.49
-0.40
-2.50
-15.52
-14.04
3
Margins & Profitability
66.5%
-275.9%
-265.6%
-252.0%
-323.9%
-344.0%
20.1%
-6.2%
Returns
-79.0%
-239.6%
-180.1%
-155.0%
-106.7%
Historical Growth (CAGR)
-36.7%
-31.8%
-12.3%
-49.0%
37.8%
11.5%
-51.4%
13.8%
-2.0%
Analyst Forecasts
Buy
1
34.4%
60.8%
Mar 8, 2027
-$0.21
-38.2%
$16.28M
27.7%
Fair Value Estimates
N/A
N/A
N/A
N/A
$6.00
1076.5%
Cash Flow
$-173.71M
$-173.71M
$-184.5M
-$1.12
-$1.12
-431.8%
Income Statement
$53.64M
$35.67M
$-148.01M
$-142.47M
$-135.18M
-$0.97
$372.49K
$-938.76K
144
Add to Watchlist
Select watchlists to add or remove CHRS